Clinical & Diagnostic
Bespak Completes Separation from Recipharm,Shifts Focus to Low GWP Inhalers
Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Gr...
April 02, 2024 | News
GE HealthCare Completes Acquisition of MIM Software, Enhancing Precision Care Portfolio
With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated sol...
April 02, 2024 | News
Integra LifeSciences Completes Acquisition of Acclarent, Expands Market Reach in ENT Surgical Solutions
Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, announced it has successfully completed it...
April 02, 2024 | News
Eisai and Biogen Seek FDA Approval for Monthly Alzheimer's Treatment Dosing
Eisai Co., Ltd. and Biogen Inc. have taken a significant step forward in the fight against Alzheimer’s disease by submitting a Supplemental Biologics...
April 01, 2024 | News
Bridge Biotherapeutics Partners with Emory University to Advance Lung Cancer Treatment
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announ...
April 01, 2024 | News
Baird Medical Devices, Inc. Introduces Next-Generation Ceramic Thyroid Ablation Needle
Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China&nb...
April 01, 2024 | News
FDA Approves Vafseo for Anemia in Dialysis Patients
SL Vifor is pleased that its partner Akebia Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Vafseo (vadadustat) ...
March 29, 2024 | News
Bridge Biotherapeutics Partners with Emory University to Combat Lung Cancer Resistance
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, ...
March 29, 2024 | News
Lunit Reveals Positive Study Results for Head and Neck Cancer Immunotherapy
Lunit, a global leader in AI-driven cancer diagnostics and therapy solutions, is thrilled to share the publication of a groundbreaking study in the prestig...
March 27, 2024 | News
TiumBio Initiates Phase 1b Trial for New Hemophilia Treatment TU7710
TiumBio Co., Ltd., a trailblazer in the biopharmaceutical landscape, dedicated to crafting groundbreaking therapies for rare and untreatabl...
March 27, 2024 | News
Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL
Takeda Receives FDA Approval for ICLUSIG as a First-Line Treatment in Ph+ ALL Takeda Pharmaceutical Company Limited (TSE: 4502; NYSE: TAK) is plea...
March 25, 2024 | News
AriBio Secures Exclusive $770M Deal for Alzheimer's Drug in China
AriBio Co., Ltd. (AriBio), announces signing of exclusive marketing rights for AR1001, an investigational drug for early Alzheimer’s disease, in Chin...
March 25, 2024 | News
Australia Grants AUD 17M to TB Alliance for Innovative Treatments
The Australian Government, through the Partnerships for a Healthy Region initiative, has announced a new AUD 17 million grant to support work with TB Allia...
March 25, 2024 | News
Lynk Pharmaceuticals Initiates Pivotal Phase III Trial for Groundbreaking Atopic Dermatitis Treatment
Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as "Lynk Pharmaceuticals"), a clinical-stage innovative drug development company, announced that it...
March 22, 2024 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
